Project: A cost effective and time saving blood test to detect six human bloodborne infectious diseases
| Acronym | SAFEBLOOD (Reference Number: 113590) |
| Duration | 01/01/2020 - 03/01/2023 |
| Project Topic | The consortium will develop a new in vitro diagnostic (IVD) test to screen donated blood for bloodborne infectious pathogens, saving blood banks time and costs required for analysis of mandatory pathogens. The IVD test is a multiplex immunoassay that simultaneously screens for six bloodborne infectious diseases per blood sample. In this project, a mix of diagnostic protein markers will be developed and validated to lockdown an IVD test ready for commercial scale-up and CE-IVD certification. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 11 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | WAMA Diagnostics | Coordinator | Switzerland |
| 2 | InfYnity Biomarkers | Partner | France |
| 3 | University Hospital of Montpellier | Partner | France |